(75% Positive) FIBROGEN, INC. (FGEN) Announces Enrollment Update for currently Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment
Director Poul Mojdeh 🟡 adjusted position in 1.4K shares (2 derivative) of INTEGRA LIFESCIENCES HOLDINGS CORP (IART) at $13.13 Transaction Date: Jan 06, 2026 | Filing ID: 000002